CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
Condition(s):Acute Myelogenous Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia With Maturation; Acute Myeloid Leukemia Without Maturation; ANLLLast Updated:December 6, 2016Unknown status